KvaliMed - a Quality Project With Focus on Patients in Antipsychotic

Clinical Trial Summary

Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04850001` - Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study
Recruiting	`NCT06122545` - Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment	N/A
Recruiting	`NCT02753192` - Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison	N/A
Active, not recruiting	`NCT05907694` - Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT04850001 - Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

Recruiting

NCT06122545 - Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment

N/A

Recruiting

NCT02753192 - Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison

N/A

Active, not recruiting

NCT05907694 - Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00750776
Study type	Observational
Source	Psychiatric Centre Rigshospitalet
Contact
Status	Terminated
Phase	N/A
Start date	August 2003
Completion date	August 2012

KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment — KvaliMed

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms